Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC9206 | Cysteamine bitartrate Featured |
![]() |
|
DC9031 | Clodronate disodium |
![]() |
|
DC9241 | Tretinoin(Retinoic acid) Featured |
Tretinoin(Retinoic acid) is a metabolite of vitamin A that plays important roles in cell growth, differentiation, and organogenesis. Retinoic acid is a natural agonist of RAR nuclear receptors, with IC50s of 14 nM for RARα/β/γ. Retinoic acid bind to PPARβ
More description
|
![]() |
DC9043 | Pramipexole 2HCL monohydrate Featured |
Pramipexole dihydrochloride hydrate is a selective dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole dihydrochloride hydrate can be used for the resear
More description
|
![]() |
DC9743 | CB1954(Tretazicar) Featured |
Tretazicar (CB 1954), an antitumor prodrug, is highly selective against the Walker 256 rat tumour line. Tretazicar is enzymatically activated to generate a bifunctional agent, which can form DNA-DNA interstrand cross-links. Tretazicar in rat cells involve
More description
|
![]() |
DC8094 | Ys-49 Featured |
YS 49 inhibits Ang II-stimulated proliferation of VSMCs via induction of HO-1.
More description
|
![]() |
DC7535 | Y-320 Featured |
Y-320 is a new phenylpyrazoleanilide immunomodulator; inhibits IL-17 production by CD4 T cells stimulated with IL-15 with IC50 values of 20 to 60 nM.
More description
|
![]() |
DC7534 | XMD8-92 Featured |
XMD8-92 is highly selective ERK5/BMK1 inhibitor with Kd values of 80, 190, 600 and 890 nM for BMK1, DCAMKL2, PLK4 and TNK1 respectively ; displays selectivity over 402 diverse kinases.
More description
|
![]() |
DC7688 | XMD-17-51 Featured |
XMD-17-51 is a potent NUAK1-specific NUAK1 inhibitor
More description
|
![]() |
DC7624 | XMD17-109 Featured |
XMD17-109 is a novel, specific ERK-5 inhibitor with an EC50 4.2 uM in HEK293 cells.
More description
|
![]() |
DC3123 | XL388 Featured |
XL388 is a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR).
More description
|
![]() |
DC7043 | XL-228 Featured |
XL228 is a protein kinase inhibitor targeting IGF1R, the Aurora kinases, FGFR1-3, ABL and SRC family kinases.
More description
|
![]() |
DC7647 | Ximelagatran Featured |
Ximelagatran is an orally active direct thrombin inhibitor.
More description
|
![]() |
DC5006 | XAV-939 Featured |
XAV-939 selectively inhibits Wnt/β-catenin-mediated transcription through tankyrase1/2 inhibition with IC50 of 11 nM/4 nM, regulates axin levels and does not affect CRE, NF-κB or TGF-β.
More description
|
![]() |
DC11312 | Xanthine amine congener Featured |
Xanthine amine congener (XAC) is a non-selective adenosine receptor antagonist with Kb values of 83, 25, and 15 nM for rat PC12 cells, human platelets that endogenously express adenosine A2A receptors, and rat fat cells that endogenously express A1 recept
More description
|
![]() |
DC23204 | WZ8040 Featured |
WZ8040 is a potent, mutant-selective, irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I) and is 100-fold less potent against wild-type EGFR.
More description
|
![]() |
DC8244 | wp1066(STAT Inhibitor III) Featured |
WP1066 is a cell-permeable inhibitor of STAT3 that directs dephosphorylation and nuclear export of constitutively phosphorylated STAT.
More description
|
![]() |
DC7340 | Wnt-C59 Featured |
Wnt-C59(C59) is a very potent and highly selective Wnt signaling antagonist with an IC50 ~ 74 pM in the Wnt signaling reporter assay.
More description
|
![]() |
DC9812 | IWP-4 Featured |
Wnt Inhibitor IWP-4 is a potent inhibitor of Wnt/β-catenin signaling (IC50 = 25 nM).
More description
|
![]() |
DC20201 | WAY-316606 Featured |
WAY-316606, a specific antagonist of SFRP1, functions as an inhibitor of canonical Wnt/β-catenin signalling in the human hair bulb.
More description
|
![]() |
DC24128 | WAY 100635 maleate salt Featured |
WAY-100635 is a potent, silent antagonist of 5-HT1A receptors (IC50 = 2.2 nM; Ki = 0.84 nM for rat 5-HT1A receptors). Displays 100-fold selectivity for 5-HT1A over other 5-HT subtypes. Also exhibits agonist activity at dopamine D4 receptors.
More description
|
![]() |
DC1016 | VU-0357121(VU0357121) Featured |
VU0357121 is a novel allosteric modulator of mGlu5 with EC50 of 33 nM.
More description
|
![]() |
DC7337 | VS-5584 Featured |
VS-5584 (SB2343) is a potent and selective dual PI3K/mTOR inhibitor for mTOR, PI3Kα/β/δ/γ with IC50 of 3.4 nM and 2.6-21 nM, respectively.
More description
|
![]() |
DC8229 | Vorapaxar Sulfate (SCH 530348) Featured |
Vorapaxar is an antagonist of the protease activated receptor-1 (PAR-1), the principal platelet thrombin receptor.
More description
|
![]() |
DC7752 | Vidofludimus(4SC-101; SC12267) Featured |
Vidofludimus(4SC-101; SC12267) is a novel immunosuppressive drug that inhibits DHODH; inhibits IL-17 secretion in vitro independently of effects on lymphocyte proliferation.
More description
|
![]() |
DC7528 | VGX-1027(GIT 27) Featured |
VGX-1027(GIT27) is an isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages.
More description
|
![]() |
DCAPI1202 | Vecuronium Bromide Featured |
Vecuronium Bromide
More description
|
![]() |
DC8636 | Varenicline Featured |
Varenicline(CP 526555;Champix) is a selective α4β2 nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.
More description
|
![]() |
DCJ-027 | Varenicline tartrate Featured |
Varenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.
More description
|
![]() |
DC12340 | Ursocholic acid |
Ursocholic acid, a bile acid found predominantly in bile of mammals, is an inhibitor of 7α-hydroxysteroid dehydrogenase and hepatocyte nuclear factor 1α.
More description
|
![]() |